Tricyclic antidepressants, but not the selective serotonin reuptake inhibitor fluoxetine, bind to the S1S2 domain of AMPA receptors

Archives of Biochemistry and Biophysics

Volumn 458, Issue 2, 2007, Pages 213-219

  Stoll, Laura ^a   Seguin, Sandlin ^a   Gentile, Lisa ^a  

^a WESTERN WASHINGTON UNIVERSITY   (United States)

Author keywords

AMPA; Fluoxetine; Ionotropic glutamate receptors; S1S2; Selective serotonin reuptake inhibitor; Tricyclic antidepressants

Indexed keywords

AMPA RECEPTOR; DESIPRAMINE; FLUOXETINE; GLUTAMATE RECEPTOR 2; IMIPRAMINE; MAPROTILINE; NORTRIPTYLINE; TRICYCLIC ANTIDEPRESSANT AGENT; TRIMIPRAMINE;

ARTICLE; BINDING ASSAY; DRUG BINDING; DRUG STRUCTURE; FLUORESCENCE ANALYSIS; PRIORITY JOURNAL;

ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ANTIDEPRESSIVE AGENTS, TRICYCLIC; BINDING SITES; DNA, COMPLEMENTARY; FLUOXETINE; MUTATION; PEPTIDE HYDROLASES; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, AMPA; SEROTONIN UPTAKE INHIBITORS;

EID: 33846836937     PISSN: 00039861     EISSN: 10960384     Source Type: Journal    
DOI: 10.1016/j.abb.2006.12.004     Document Type: Article

References (33)

1. Skolnick P., Legutko B., Li X., and Bymaster F.P. Pharmacol. Res. 43 (2001) 411-422
2. Skolnick P. J. Clin. Psychiatry 63 Suppl. 2 (2002) 19-23
3. Goodman Gilman A., Rall T.W., Nies A.S., and Taylor P. Goodman and Gilman's The Pharmacological Basis of Therapeutics. eighth edition (1990), Pergamon Press, New York
4. Schatzberg A.F., and Nemeroff C.B. The American Psychiatric Press Textbook of Psychopharmacology (1995), American Psychiatric Press, Inc., Washington, DC
5. Cai Z., and McCaslin P. Eur. J. Pharmacol. 219 (1992) 53-57
6. Palucha A., and Pilc A. Drug News Perspect. 18 (2005) 262-268
7. Paul I.A., and Skolnick P. Ann. NY Acad. Sci. 1003 (2003) 250-272
8. Tohda M., Urushihara H., and Nomura Y. Neurochem. Int. 26 (1995) 53-58
9. Armstrong N., and Gouaux E. Neuron 28 (2000) 165-181
10. Chen G.-Q., Sun Y., Jin R., and Gouaux E. Protein Sci. 7 (1998) 2623-2630
11. Chen G.-Q., and Gouaux E. Proc. Natl. Acad. Sci. USA 94 (1997) 13431-13436
12. Furukawa H., and Gouaux E. EMBO J. 22 (2003) 2873-2885
13. Reynolds I.J., and Miller R.J. Br. J. Pharmacol. 95 (1988) 95-102
14. Sills M.A., and Loo P.S. Mol. Pharmacol. 36 (1989) 160-165
15. Stoll L., and Gentile L. Biochem. Biophys. Res. Commun. 333 (2005) 622-627
16. Trullas R., and Skolnick P. Eur. J. Pharmacol. 185 (1990) 1-10
17. Legutko B., Li X., and Skolnick P. Neuropharmacology 40 (2001) 1019-1027
18. Alt A., Witkin J.M., and Bleakman D. Curr. Pharm. Des. 11 (2005) 1511-1527
19. Alt A., Nisenbaum E.S., Bleakman D., and Witkin J.M. Biochem. Pharmacol. 71 (2006) 1273-1288
20. Coppell A.L., Pel Q., and Zetterstrom T.S.C. Neuropharmacology 44 (2003) 903-910
21. Dias B.G., Banerjee S.B., Duman R.S., and Valdya V.A. Neuropharmacology 45 (2003) 553-563
22. Nibuya M., Merinobu S., and Duman R.S. J. Neurosci. 15 (1995) 7539-7547
23. Tan C.-H., He X., Yang J., and Ong W.-Y. Exp. Brain Res. Nov. 30 (2005) 1-9
24. Martinez-Turrillas R., Frechilla D., and Del Rio J. Neuropharmacology 43 (2002) 1230-1237
25. Spivak V., Lin A., Beebe P., Stoll L., and Gentile L. Lipids 39 (2004) 811-819
26. Eftink M.R., and Ghiron A. Biochemistry 15 (1976) 672-680
27. Lakowicz J.R. Principles of Fluorescence Spectroscopy. Second ed. (1990), Kluwer Academic/Plenum Publishers, New York
28. Natale P., den Blaauwen T., van der Does C., and Driessen A.J.M. Biochemistry 44 (2005) 6424-6432
29. Tyagi N.K., Goyal P., Kuman A., Pandey D., Siess W., and Kinne R.K.H. Biochemistry 44 (2005) 15514-15524
30. Sheehan D. Physical Biochemistry: Principles and Applications (2000), Wiley, Chichester
31. Li X.-M. Biochemistry 43 (2004) 10285-10294
32. Svenningeson P., Trovara E.T., Liu F., Fienberg A.A., Nomikos G.G., and Greengard P. Proc. Natl. Acad. Sci. USA 99 (2002) 3188-3193
33. Svenningsson P., Tzavara E.T., Witkin J.M., Fienberg A.A., Nomikos G.G., and Greengard P. Proc. Natl. Acad. Sci. USA 99 (2002) 3182-3187